About the Product

Description


Fucoziff I Tablet containing Fluconazole and Ivermectin is used for the management of fungal and parasitic infections. It helps control infection-causing organisms and supports effective recovery from infection-related conditions.

Fluconazole works as an antifungal agent by inhibiting the synthesis of fungal cell membranes, while Ivermectin acts as an anti-parasitic agent that interferes with the nerve and muscle function of susceptible parasites. Together, they provide broad anti-infective support.

The tablet is prescribed in clinical practice for selected fungal and parasitic infections where combination therapy is considered appropriate, leading to consistent prescription demand.

With the continued need for effective anti-infective therapies and growing demand for comprehensive infection management solutions, this product offers strong business potential for retailers and distributors. Its combination formulation, established therapeutic relevance, and steady market demand make it a reliable product for growth in the anti-infective segment.

Some patients may experience nausea, vomiting, abdominal discomfort, diarrhea, headache, dizziness, fatigue, or skin rash. Rarely, liver function abnormalities, severe allergic reactions, neurological effects, or serious skin reactions may occur and require immediate medical attention.

Fucoziff I Tablet is indicated for fungal infections and parasitic infestations where combination therapy is considered appropriate by a healthcare professional. It helps control susceptible fungal organisms and parasites, reducing infection-related symptoms and supporting recovery.

This medicine should be used strictly under medical supervision. Liver function monitoring may be required in some patients, especially during prolonged therapy. Use cautiously in patients with liver disease, neurological disorders, or those taking medications that may interact with Fluconazole. Follow the prescribed dosage and duration carefully, and do not self-medicate.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Fluconazole 300mg + Ivermectin 12mg Tablet in the PCD pharma franchise market?

Fluconazole 300mg + Ivermectin 12mg Tablet has strong demand in the dermatology, anti-infective, and skin care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on dermatology and specialty healthcare portfolios.

Why should medical distributors include Fluconazole + Ivermectin Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for fungal and parasitic skin infection management under medical supervision. Fluconazole 300mg is a broad-spectrum antifungal agent used to treat various fungal infections Ivermectin 12mg is an antiparasitic agent effective against certain parasitic infestations Commonly prescribed for fungal skin infections, parasitic skin conditions, and mixed dermatological infections as determined by healthcare professionals Helps provide comprehensive management of infection-related skin disorders This strengthens a robust dermatology and anti-infective product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Fluconazole 300mg + Ivermectin 12mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong demand in dermatology practice, repeat prescriptions, reliable supply chain support, growing market acceptance, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.